Prominent companies such as Valbiotis, Resverlogix, Caelus Health, SciMar, Boston Therapeutics, MicroBiome Therapeutics, and others are developing potential drug candidates to boost the Prediabetes treatment scenario. Out of all the emerging therapies, the late-stage product TOTUM-63 (VALBIOTIS) has shown promising results and will significantly impact the Prediabetes treatment market.Los Angeles, USA , June 02, 2021 (GLOBE NEWSWIRE) Current Therapies and Emerging Drugs in the Prediabetes Pip
Alzheimer’s Disease pipeline shows progress in the clinical trials with the upcoming therapies such as BAN2401, Gantenerumab, Bryostatin-1, INB03, AZT-211,.
5+ key companies are developing Non-cystic Fibrosis Bronchiectasis therapies. These key players are
TSRL Inc, Santhera Pharmaceuticals, Chiesi Farmaceutici, Novartis, InsMed, Zambon, and others have their NCFBE drug candidates in the different phases of clinical development.
In September 2020, the U.S. biotech
Insmed trumpeted updated phase 2 data from its brensocatib showing the drug prolonged time to exacerbations caused by the rare lung disease known as Non-cystic Fibrosis Bronchiectasis (NCFBE).
Insmed develops
INS1007, an investigational, first-in-class, oral, selective, reversible inhibitor of dipeptidyl peptidase I (DPP1) designed to treat Non-cystic Fibrosis Bronchiectasis patients.
The U.S. Food and Drug Administration (FDA) has permitted breakthrough therapy designation for
Novel Rheumatoid Arthritis drugs succeed in the clinical trials: A status report by DelveInsight globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Psoriasis Pipeline Insight 2021 | Latest Advancements in Clinical Trials to Improve Treatment
Psoriasis treatment has expanded dramatically over the past decade, and the growth shows no signs of stopping, as many prominent players such as
Abbvie, Jannsen, Dermavant Sciences, UCB, Eli Lilly and Company, Boehringer Ingelheim, Pfizer, Arcutis Biotherapeutics, Amgen, Mylan, Clover Biopharmaceuticals, Sienna Biopharmaceuticals, Fresenius Kabi, Celltrion, Bristol Myers Squibb, LEO Pharma, Crescita Therapeutics, GlaxoSmithKline, Coherus BioSciences, Fujifilm Kyowa Kirin Biologics, Zydus Cadilla, Shanghai Henlius Biotech, Hetero Biopharma, CinnaGen, Biocad, Torrent Pharmaceuticals, Alvotech, Maruho Co., Ltd.,
Arcutis Biotherapeutics, Inc., Eli Lilly and Company, Can-Fite Biopharma, MetrioPharm, Provectus Pharmaceuticals, Sienna Biopharmaceuticals